So very true.. if we based only on effectiveness; there would not be any given.
Actually, Lido (one of the oldest common medication) has a lot benefits. In some studies in comparrision to Amio there is not much difference in outcome but definitely in costs...
True, not as used medication as it used to.. but let's not throw it out ...
Yes, it has use but as was mentioned, 2nd line for the most part.
"The overall benefits of lidocaine for the treatment arrhythmias in cardiac arrest has come under scrutiny. It has been shown to have no short term or long term efficacy in cardiac arrest."
It's still in our arrest protocol but only as a second line after amiodorone.
It is really unfair to compare antiarrhythmics head-to-head across all causes of WCT and SCA...and it has little to do with cost. They certainly have overlapping areas of concern, but their mechanisms are all different.
Saying lidocaine is ineffective and thus "second line" for WCT's or SCA would be like saying defibrillation is ineffective in cardiac arrest because it doesn't work with a non-shockable rhythm.
Lidocaine is best used in ischemic tissues, and it will be piss poor at terminating arrhythmias due to other substrates. Not ischemia related? Not Na-channel blocker related? Probably should pick another drug.
The old: "WCT = Amio/Procainamide then Lido," is poorly predictive of success because we're taking the Throw Spaghetti On Wall, See What Sticks approach to its treatment.
We must consider the likely underlying pathophysiology of the arrhythmia and the drug (or drugs) most likely to work for the cause. If we don't follow this model, we shouldn't be surprised when a drug doesn't work. (Nor should we blame the drug!)
almost every patient I've hung amio on for pulsatile VT has tanked out their BP
The drug exerts class Ia, II, III, and IV antiarrhythmic effects. Combining the loss of inotropy and SVR from Ca-channel blockade with the loss in chronotropy from B-blockade maaaay have something to do with your hypotension post-amio ;-)
Also one of the excipients packaged with amiodarone (polysorbate 80) exhibits strong cardiodepressor effects (chiefly negative inotropy) possibly due to histamine release.